Trademark Overview
On Wednesday, April 15, 2026, a trademark application was filed for PEBF with the United States Patent and Trademark Office. The USPTO has given the PEBF trademark a serial number of 99765783. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 15, 2026. This trademark is owned by Atropos Health, Inc.. The PEBF trademark is filed in the Advertising, Business and Retail Services, Communication Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Scientific and technological services, including the design, development, and implementation of proprietary study designs and analytical methodologies (e.g., Prognostogram, Pathways) to generate, quantify, and validate large volumes of per-combination precision evidence based findings from real-world data sources; providing non-downloadable computer software platforms for the creation, organization, tagging, and management of internal and external healthcare evidence, including the generation and storage of precision evidence based findings for use in clinical research and analytics; providing curated, personalized, and cited evidence in the form of precision evidence based findings, including individual statistical findings for specific intervention-baseline-outcome combinations, specifically designed as primary training material to inform and benchmark large language models (LLMs) and artificial intelligence (AI) in the healthcare domain
Electronic transmission of data, documents, and digital content, specifically personalized precision evidence based findings to facilitate shared decision-making, provider care assistance, and commercial and brand planning; providing telecommunications access to a proprietary library and database of novel studies and precision evidence based findings for both human and automated consumption, including the provision of application programming interfaces (APIs) for data access
Providing business consulting, management, and administrative services in the healthcare industry, utilizing precision evidence based findings for strategic planning, operational efficiency, and evidence-based decision-making for healthcare providers, payers, and pharmaceutical companies; providing business intelligence and predictive data analysis services, including content creation and market share analysis, using precision evidence based findings to inform formulary guidance, medical benefit positions, and commercial and brand planning; business advisory services focused on healthcare cost containment, precision adjudication of high-cost therapies, and streamlining prior authorization processes by applying granular, personalized evidence-based findings quantifying outcomes for specific combinations of clinical interventions, patient baselines, and health outcomes
Providing medical and clinical information services, including the surfacing and delivery of precision evidence based findings relevant to an individual patient's clinical profile to inform personalized medicine, patient risk stratification, and patient care decisions at the point of care; providing health outcome and medical analysis services, including the quantification of risk and the monitoring of outcomes per case, based on precision evidence based findings to support providers, payers, and patients
